Huma acquires Alcedis to expand clinical trial platform
Posted:
The UK-based company Huma will form an advanced clinical trials division offering digital health solutions for each phase of the development process. Read more here.
Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) are exploring a key question in cancer immunotherapy: how to “wire” engineered natural killer (NK) cells so they respond faster and hit harder when they encounter…
SMARTWATCH screening has been shown to significantly improve atrial fibrillation detection in older, high-risk patients, with researchers reporting substantially higher diagnosis rates compared with standard care.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us